We really believe that biosimilars line up as a value accretion for every constituency, whether it’s the patient, the practice, or the payer, said Lee Schwartzberg, MD, FACP, executive director, West Cancer Center.
We really believe that biosimilars line up as a value accretion for every constituency, whether it’s the patient, the practice, or the payer, said Lee Schwartzberg, MD, FACP, executive director, West Cancer Center.
Transcript
OneOncology announced that its practices have begun administering the 2 cancer biosimilars on the US market. How will this help address financial toxicity?
We were very proud that OneOncology jumped in as the first group to endorse therapeutic biosimilars in the oncology space. We really believe that biosimilars line up as a value accretion for every constituency, whether it’s the patient, the practice, the payer, because you’re giving a high-value drug at a lower cost and therefore across the chain of value, it’s good for everyone. So, there’s education around biosimilars. We’ve been using supportive care biosimilars for a few years.
Some people feel there might be a different bar for therapeutics. I’ve looked at the totality of evidence about what allows a biosimilar to come to market, which is based on a very strong analytic similarity, as well as some clinical trials. We can extrapolate the use of these drugs into the same conditions that we would with the originator drug. I feel very strongly that we’re going to move wholesale into suing biosimilars where there appropriate in the therapeutic oncology space, and it will be great for everyone.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More